These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 16143709)

  • 1. Comparison of the efficacy of ramoplanin and vancomycin in both in vitro and in vivo models of clindamycin-induced Clostridium difficile infection.
    Freeman J; Baines SD; Jabes D; Wilcox MH
    J Antimicrob Chemother; 2005 Oct; 56(4):717-25. PubMed ID: 16143709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oritavancin does not induce Clostridium difficile germination and toxin production in hamsters or a human gut model.
    Freeman J; Marquis M; Crowther GS; Todhunter SL; Fawley WN; Chilton CH; Moeck G; Lehoux D; Wilcox MH
    J Antimicrob Chemother; 2012 Dec; 67(12):2919-26. PubMed ID: 22899803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of oritavancin versus vancomycin as treatments for clindamycin-induced Clostridium difficile PCR ribotype 027 infection in a human gut model.
    Baines SD; O'Connor R; Saxton K; Freeman J; Wilcox MH
    J Antimicrob Chemother; 2008 Nov; 62(5):1078-85. PubMed ID: 18772161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of vancomycin against epidemic Clostridium difficile strains in a human gut model.
    Baines SD; O'Connor R; Saxton K; Freeman J; Wilcox MH
    J Antimicrob Chemother; 2009 Mar; 63(3):520-5. PubMed ID: 19112083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of REP3123 on toxin and spore formation in Clostridium difficile, and in vivo efficacy in a hamster gastrointestinal infection model.
    Ochsner UA; Bell SJ; O'Leary AL; Hoang T; Stone KC; Young CL; Critchley IA; Janjic N
    J Antimicrob Chemother; 2009 May; 63(5):964-71. PubMed ID: 19251726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of a short (4 day) course of oritavancin in the treatment of simulated Clostridium difficile infection using a human gut model.
    Chilton CH; Freeman J; Crowther GS; Todhunter SL; Wilcox MH
    J Antimicrob Chemother; 2012 Oct; 67(10):2434-7. PubMed ID: 22723601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of NVB302 versus vancomycin activity in an in vitro human gut model of Clostridium difficile infection.
    Crowther GS; Baines SD; Todhunter SL; Freeman J; Chilton CH; Wilcox MH
    J Antimicrob Chemother; 2013 Jan; 68(1):168-76. PubMed ID: 22966180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of planktonic and biofilm-associated communities of Clostridium difficile and indigenous gut microbiota in a triple-stage chemostat gut model.
    Crowther GS; Chilton CH; Todhunter SL; Nicholson S; Freeman J; Baines SD; Wilcox MH
    J Antimicrob Chemother; 2014 Aug; 69(8):2137-47. PubMed ID: 24788662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential of lactoferrin to prevent antibiotic-induced Clostridium difficile infection.
    Chilton CH; Crowther GS; Śpiewak K; Brindell M; Singh G; Wilcox MH; Monaghan TM
    J Antimicrob Chemother; 2016 Apr; 71(4):975-85. PubMed ID: 26759363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ambush of Clostridium difficile spores by ramoplanin: activity in an in vitro model.
    Kraus CN; Lyerly MW; Carman RJ
    Antimicrob Agents Chemother; 2015 May; 59(5):2525-30. PubMed ID: 25691641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of vancomycin extended-dosing regimens for treatment of simulated Clostridium difficile infection within an in vitro human gut model.
    Crowther GS; Chilton CH; Longshaw C; Todhunter SL; Ewin D; Vernon J; Karas A; Wilcox MH
    J Antimicrob Chemother; 2016 Apr; 71(4):986-91. PubMed ID: 26755495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rifalazil treats and prevents relapse of clostridium difficile-associated diarrhea in hamsters.
    Anton PM; O'Brien M; Kokkotou E; Eisenstein B; Michaelis A; Rothstein D; Paraschos S; Kelly CP; Pothoulakis C
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3975-9. PubMed ID: 15388461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of metronidazole on growth and toxin production by epidemic Clostridium difficile PCR ribotypes 001 and 027 in a human gut model.
    Freeman J; Baines SD; Saxton K; Wilcox MH
    J Antimicrob Chemother; 2007 Jul; 60(1):83-91. PubMed ID: 17483547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of simulated Clostridium difficile infection in a human gut model by fidaxomicin first line and after vancomycin or metronidazole failure.
    Chilton CH; Crowther GS; Freeman J; Todhunter SL; Nicholson S; Longshaw CM; Wilcox MH
    J Antimicrob Chemother; 2014 Feb; 69(2):451-62. PubMed ID: 24003182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of tigecycline and vancomycin administration on established Clostridium difficile infection.
    Theriot CM; Schumacher CA; Bassis CM; Seekatz AM; Young VB
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1596-604. PubMed ID: 25547352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clostridium difficile--a spectrum of virulence and analysis of putative virulence determinants in the hamster model of antibiotic-associated colitis.
    Borriello SP; Ketley JM; Mitchell TJ; Barclay FE; Welch AR; Price AB; Stephen J
    J Med Microbiol; 1987 Aug; 24(1):53-64. PubMed ID: 3612744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clindamycin-induced colitis.
    Fekety R; Silva J; Browne RA; Rifkin GD; Ebright JR
    Am J Clin Nutr; 1979 Jan; 32(1):244-50. PubMed ID: 760500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Berberine blocks the relapse of Clostridium difficile infection in C57BL/6 mice after standard vancomycin treatment.
    Lv Z; Peng G; Liu W; Xu H; Su J
    Antimicrob Agents Chemother; 2015 Jul; 59(7):3726-35. PubMed ID: 25824219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrence of dual-strain Clostridium difficile infection in an in vitro human gut model.
    Crowther GS; Chilton CH; Todhunter SL; Nicholson S; Freeman J; Wilcox MH
    J Antimicrob Chemother; 2015 Aug; 70(8):2316-21. PubMed ID: 25925596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tigecycline does not induce proliferation or cytotoxin production by epidemic Clostridium difficile strains in a human gut model.
    Baines SD; Saxton K; Freeman J; Wilcox MH
    J Antimicrob Chemother; 2006 Nov; 58(5):1062-5. PubMed ID: 17030519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.